TAL1 and leukemia: In our study, the incidence of DIC was much higher in patients carrying SIL-TAL1, and most DIC accompanying with TLS occurred in the early stage of induction therapy, which indicated that DIC may also be related to the breaking down of leukemia cells during chemotherapy.